NCT05623189 — "HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes" trial site landscape

Public-registry site landscape for NCT05623189, “HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes”, a Nonalcoholic Steatohepatitis (NASH) study sponsored by HighTide Biopharma Pty Ltd. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT05623189 (registry record)
Study title	HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes
Official title	A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of HTD1801 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis Who Have Type 2 Diabetes (T2DM) or Pre-Diabetes
Sponsor	HighTide Biopharma Pty Ltd
Condition(s)	Nonalcoholic Steatohepatitis (NASH); Type 2 Diabetes
Phase	PHASE2
Listed sites	45
Site countries	United States, Hong Kong, Puerto Rico

Patient-friendly overview of this study: eichor.com/study/NCT05623189.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT05623189 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related trials

Other Nonalcoholic Steatohepatitis (NASH) trials

← Eichor home · All tracked trials · Nonalcoholic Steatohepatitis (NASH) studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →